Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-09

Clinical Trial Update: Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy [Phase 2, Phase 3]

View source ↗

Summary

A multi-phase trial investigating lifestyle and pharmacological interventions for hypertrophic cardiomyopathy has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Conditions: Hypertrophic Cardiomyopathy | Phase 2, Phase 3 | Status: COMPLETED